| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | 2.66e-05 | 479 | 51 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.28e-04 | 9 | 51 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 2.84e-04 | 10 | 51 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | structural constituent of ribosome | 1.22e-03 | 183 | 51 | 4 | GO:0003735 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.45e-03 | 192 | 51 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 1.56e-03 | 23 | 51 | 2 | GO:0140994 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 2.66e-03 | 30 | 51 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 2.66e-03 | 30 | 51 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.68e-03 | 227 | 51 | 4 | GO:0051015 | |
| GeneOntologyBiologicalProcess | RNA splicing | 2.96e-05 | 502 | 51 | 8 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 5.71e-05 | 551 | 51 | 8 | GO:0006397 | |
| GeneOntologyCellularComponent | CKM complex | 5.81e-05 | 5 | 51 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 7.09e-05 | 576 | 51 | 8 | GO:0015629 | |
| GeneOntologyCellularComponent | mediator complex | 1.00e-04 | 37 | 51 | 3 | GO:0016592 | |
| GeneOntologyCellularComponent | cytosolic large ribosomal subunit | 4.04e-04 | 59 | 51 | 3 | GO:0022625 | |
| GeneOntologyCellularComponent | actin filament | 4.42e-04 | 146 | 51 | 4 | GO:0005884 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 4.46e-04 | 61 | 51 | 3 | GO:0000307 | |
| GeneOntologyCellularComponent | nuclear speck | 6.10e-04 | 431 | 51 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 7.75e-04 | 17 | 51 | 2 | GO:0090443 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 8.71e-04 | 18 | 51 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 8.71e-04 | 18 | 51 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 8.71e-04 | 18 | 51 | 2 | GO:0071010 | |
| GeneOntologyCellularComponent | ribosomal subunit | 1.28e-03 | 194 | 51 | 4 | GO:0044391 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 1.97e-03 | 27 | 51 | 2 | GO:0005865 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 2.18e-03 | 1194 | 51 | 9 | GO:1990904 | |
| GeneOntologyCellularComponent | myofilament | 2.76e-03 | 32 | 51 | 2 | GO:0036379 | |
| GeneOntologyCellularComponent | large ribosomal subunit | 3.00e-03 | 118 | 51 | 3 | GO:0015934 | |
| GeneOntologyCellularComponent | cytosolic ribosome | 3.45e-03 | 124 | 51 | 3 | GO:0022626 | |
| GeneOntologyCellularComponent | ribosome | 4.06e-03 | 267 | 51 | 4 | GO:0005840 | |
| MousePheno | abnormal sarcomere morphology | 2.72e-05 | 77 | 32 | 4 | MP:0004090 | |
| Domain | Ribosomal_L44e | 7.02e-06 | 2 | 50 | 2 | IPR000552 | |
| Domain | Ribosomal_L44 | 7.02e-06 | 2 | 50 | 2 | PF00935 | |
| Domain | Ribosomal_L44e | 7.02e-06 | 2 | 50 | 2 | PD002841 | |
| Domain | RIBOSOMAL_L44E | 7.02e-06 | 2 | 50 | 2 | PS01172 | |
| Domain | - | 7.02e-06 | 2 | 50 | 2 | 3.10.450.80 | |
| Domain | Striatin | 2.10e-05 | 3 | 50 | 2 | PF08232 | |
| Domain | THRAP3_BCLAF1 | 2.10e-05 | 3 | 50 | 2 | IPR029199 | |
| Domain | THRAP3_BCLAF1 | 2.10e-05 | 3 | 50 | 2 | PF15440 | |
| Domain | Striatin_N | 2.10e-05 | 3 | 50 | 2 | IPR013258 | |
| Domain | S1 | 1.95e-04 | 8 | 50 | 2 | PF00575 | |
| Domain | Ribosomal_zn-bd | 2.50e-04 | 9 | 50 | 2 | IPR011332 | |
| Domain | S1 | 3.12e-04 | 10 | 50 | 2 | PS50126 | |
| Domain | Znf_C2H2_matrin | 4.56e-04 | 12 | 50 | 2 | IPR000690 | |
| Domain | S1 | 4.56e-04 | 12 | 50 | 2 | SM00316 | |
| Domain | S1_dom | 4.56e-04 | 12 | 50 | 2 | IPR022967 | |
| Domain | S1_domain | 4.56e-04 | 12 | 50 | 2 | IPR003029 | |
| Domain | FKBP_PPIASE | 8.23e-04 | 16 | 50 | 2 | PS50059 | |
| Domain | FKBP_C | 8.23e-04 | 16 | 50 | 2 | PF00254 | |
| Domain | ZF_MATRIN | 1.05e-03 | 18 | 50 | 2 | PS50171 | |
| Domain | PPIase_FKBP_dom | 1.29e-03 | 20 | 50 | 2 | IPR001179 | |
| Domain | NA-bd_OB-fold | 1.43e-03 | 83 | 50 | 3 | IPR012340 | |
| Domain | G-protein_beta_WD-40_rep | 1.53e-03 | 85 | 50 | 3 | IPR020472 | |
| Domain | ZnF_U1 | 2.72e-03 | 29 | 50 | 2 | SM00451 | |
| Domain | Znf_U1 | 2.72e-03 | 29 | 50 | 2 | IPR003604 | |
| Pathway | REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL | 1.86e-04 | 180 | 42 | 5 | MM15324 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.29e-04 | 724 | 42 | 9 | M16843 | |
| Pathway | REACTOME_RRNA_PROCESSING | 3.40e-04 | 205 | 42 | 5 | M27685 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.84e-04 | 612 | 42 | 8 | MM15547 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | ZNF346 SRSF10 RPL36AL RPL36A BCLAF1 SF3A1 PDCD11 SNRPC THRAP3 MRPS22 | 4.67e-11 | 330 | 51 | 10 | 33301849 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ZNF346 SRSF10 TENT4B RPL36A SUPT6H BCLAF1 SF3A1 PDCD11 SNRPC THRAP3 RPL8 PUS7 FTSJ3 | 1.09e-10 | 807 | 51 | 13 | 22681889 |
| Pubmed | SRSF10 RPL36AL RPL36A BCLAF1 SCML1 SF3A1 PDCD11 SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 5.10e-10 | 731 | 51 | 12 | 29298432 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | STRN3 STRN SRSF10 SUPT6H BCLAF1 SF3A1 DYRK1A PDCD11 SNRPC THRAP3 MRPS22 | 2.96e-09 | 670 | 51 | 11 | 22990118 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 4.25e-09 | 163 | 51 | 7 | 22113938 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK8 SRSF10 BCLAF1 CDK19 DYRK1A PDCD11 NEB SNRPC THRAP3 FKBP5 FTSJ3 | 4.32e-09 | 695 | 51 | 11 | 23602568 |
| Pubmed | ZNF346 RPL36AL RPL36A SF3A1 ZNF735 PEX1 PDCD11 SNRPC THRAP3 MRPS22 FKBP5 RPL8 FTSJ3 | 8.07e-09 | 1153 | 51 | 13 | 29845934 | |
| Pubmed | SRSF10 RPL36AL TENT4B RPL36A BCLAF1 SF3A1 PDCD11 THRAP3 MRPS22 RPL8 FTSJ3 | 3.28e-08 | 847 | 51 | 11 | 35850772 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 5.38e-08 | 361 | 51 | 8 | 30344098 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SRSF10 TENT4B RPL36A SUPT6H BCLAF1 SF3A1 PDCD11 URB2 THRAP3 RPL8 FTSJ3 | 1.57e-07 | 989 | 51 | 11 | 36424410 |
| Pubmed | 1.74e-07 | 421 | 51 | 8 | 34650049 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 2.12e-07 | 432 | 51 | 8 | 23455922 | |
| Pubmed | 2.50e-07 | 615 | 51 | 9 | 31048545 | ||
| Pubmed | 3.39e-07 | 188 | 51 | 6 | 29721183 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL36AL RPL36A SUPT6H BCLAF1 SF3A1 VPS16 SNRPC THRAP3 MRPS22 RPL8 | 3.60e-07 | 847 | 51 | 10 | 35235311 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRSF10 RPL36AL RPL36A KALRN SUPT6H BCLAF1 SF3A1 SNRPC THRAP3 MRPS22 RPL8 | 3.83e-07 | 1082 | 51 | 11 | 38697112 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SRSF10 RPL36AL RPL36A BCLAF1 PDCD11 SNRPC THRAP3 MRPS22 RPL8 | 5.65e-07 | 678 | 51 | 9 | 30209976 |
| Pubmed | 8.58e-07 | 713 | 51 | 9 | 29802200 | ||
| Pubmed | RPL36A SUPT6H BCLAF1 SF3A1 PDCD11 AIP USP6NL MRPS22 FKBP5 RPL8 PUS7 FTSJ3 | 1.20e-06 | 1487 | 51 | 12 | 33957083 | |
| Pubmed | STRN3 ZNF346 STRN SRSF10 RPL36AL TENT4B SUPT6H DYRK1A PDCD11 URB2 USP6NL MRPS22 | 1.29e-06 | 1497 | 51 | 12 | 31527615 | |
| Pubmed | CDK8 SRSF10 RPL36AL MICAL2 BCLAF1 SF3A1 THRAP3 MRPS22 FKBP5 RPL8 FTSJ3 | 1.54e-06 | 1247 | 51 | 11 | 27684187 | |
| Pubmed | 1.59e-06 | 245 | 51 | 6 | 21182205 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.77e-06 | 573 | 51 | 8 | 28330616 | |
| Pubmed | 1.83e-06 | 251 | 51 | 6 | 28077445 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | STRN3 STRN SRSF10 RPL36A BCLAF1 SF3A1 CDK19 DYRK1A THRAP3 MRPS22 FTSJ3 | 2.04e-06 | 1284 | 51 | 11 | 17353931 |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 38718356 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18571342 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31852782 | ||
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 2.11e-06 | 2 | 51 | 2 | 26416749 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32560467 | ||
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 2.11e-06 | 2 | 51 | 2 | 28855340 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 2.11e-06 | 2 | 51 | 2 | 30585107 | |
| Pubmed | Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. | 2.11e-06 | 2 | 51 | 2 | 23778535 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29112714 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27678455 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31044597 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 36006697 | ||
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 2.11e-06 | 2 | 51 | 2 | 20408451 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37378433 | ||
| Pubmed | Identification of target genes for the CDK subunits of the Mediator complex. | 2.11e-06 | 2 | 51 | 2 | 22117896 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 36602306 | ||
| Pubmed | BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells. | 2.11e-06 | 2 | 51 | 2 | 25091051 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRSF10 RPL36A SUPT6H BCLAF1 SF3A1 JAZF1 PDCD11 SNRPC THRAP3 RPL8 FTSJ3 | 2.20e-06 | 1294 | 51 | 11 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SRSF10 RPL36AL RPL36A SF3A1 PDCD11 SNRPC THRAP3 MRPS22 FKBP5 RPL8 FTSJ3 | 2.62e-06 | 1318 | 51 | 11 | 30463901 |
| Pubmed | 2.90e-06 | 272 | 51 | 6 | 31010829 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 3.05e-06 | 430 | 51 | 7 | 38172120 | |
| Pubmed | 5.45e-06 | 172 | 51 | 5 | 26336360 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SRSF10 TENT4B RPL36A SUPT6H BCLAF1 SF3A1 PDCD11 URB2 THRAP3 RPL8 FTSJ3 | 5.53e-06 | 1425 | 51 | 11 | 30948266 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 6.27e-06 | 910 | 51 | 9 | 36736316 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26002960 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30520818 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 3542712 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28151579 | ||
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 7.18e-06 | 182 | 51 | 5 | 26527279 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 8.78e-06 | 949 | 51 | 9 | 36574265 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 8.87e-06 | 714 | 51 | 8 | 28302793 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 29440396 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 10748158 | ||
| Pubmed | Cdk8 is required for establishment of H3K27me3 and gene repression by Xist and mouse development. | 1.26e-05 | 4 | 51 | 2 | 32439758 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.50e-05 | 212 | 51 | 5 | 33853758 | |
| Pubmed | 1.61e-05 | 215 | 51 | 5 | 35973513 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.61e-05 | 1024 | 51 | 9 | 24711643 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 1.79e-05 | 220 | 51 | 5 | 34091597 | |
| Pubmed | CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium. | 2.10e-05 | 5 | 51 | 2 | 36545778 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18502210 | ||
| Pubmed | 2.66e-05 | 601 | 51 | 7 | 33658012 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.78e-05 | 605 | 51 | 7 | 28977666 | |
| Pubmed | 3.04e-05 | 41 | 51 | 3 | 8724849 | ||
| Pubmed | Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle. | 3.15e-05 | 6 | 51 | 2 | 21170051 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 24100041 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 10681496 | ||
| Pubmed | STRN3 STRN KALRN MYO9A MICAL2 BCLAF1 DYRK1A THRAP3 MRPS22 RPL8 | 3.69e-05 | 1431 | 51 | 10 | 37142655 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.96e-05 | 1149 | 51 | 9 | 35446349 | |
| Pubmed | 3.99e-05 | 260 | 51 | 5 | 36199071 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 12176734 | ||
| Pubmed | Mediator CDK subunits are platforms for interactions with various chromatin regulatory complexes. | 4.41e-05 | 7 | 51 | 2 | 22668559 | |
| Pubmed | 4.59e-05 | 655 | 51 | 7 | 35819319 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 23749998 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 12721663 | ||
| Pubmed | The Cdk8/19-cyclin C transcription regulator functions in genome replication through metazoan Sld7. | 5.87e-05 | 8 | 51 | 2 | 30695077 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.73e-05 | 148 | 51 | 4 | 32538781 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.97e-05 | 954 | 51 | 8 | 36373674 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 7.03e-05 | 701 | 51 | 7 | 30196744 | |
| Pubmed | 7.38e-05 | 483 | 51 | 6 | 36912080 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 14623875 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 7.63e-05 | 486 | 51 | 6 | 30940648 | |
| Pubmed | 7.68e-05 | 711 | 51 | 7 | 33022573 | ||
| Pubmed | 7.84e-05 | 300 | 51 | 5 | 28561026 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 7.92e-05 | 1257 | 51 | 9 | 36526897 | |
| Pubmed | 9.05e-05 | 730 | 51 | 7 | 34857952 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 9.56e-05 | 162 | 51 | 4 | 31363146 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.13e-04 | 169 | 51 | 4 | 23084401 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.15e-04 | 759 | 51 | 7 | 35915203 | |
| Pubmed | 1.20e-04 | 172 | 51 | 4 | 23184937 | ||
| Pubmed | 1.25e-04 | 1335 | 51 | 9 | 29229926 | ||
| Pubmed | 1.33e-04 | 538 | 51 | 6 | 28524877 | ||
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 23563140 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.38e-04 | 1353 | 51 | 9 | 29467282 | |
| Pubmed | 1.41e-04 | 340 | 51 | 5 | 29478914 | ||
| Interaction | ZBTB2 interactions | ZNF346 SRSF10 RPL36AL RPL36A BCLAF1 SF3A1 PDCD11 SNRPC THRAP3 MRPS22 PUS7 | 1.30e-08 | 450 | 51 | 11 | int:ZBTB2 |
| Interaction | CLK3 interactions | 7.55e-08 | 220 | 51 | 8 | int:CLK3 | |
| Interaction | ZC3H18 interactions | ZNF346 SRSF10 RPL36AL RPL36A BCLAF1 SCML1 SF3A1 PDCD11 SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 1.88e-07 | 877 | 51 | 13 | int:ZC3H18 |
| Interaction | MAGEB2 interactions | 2.03e-07 | 349 | 51 | 9 | int:MAGEB2 | |
| Interaction | CSNK2A1 interactions | CCNL2 STRN SRSF10 RPL36A IGFBP3 SUPT6H BCLAF1 SF3A1 URB2 AIP THRAP3 RPL8 FTSJ3 | 5.04e-07 | 956 | 51 | 13 | int:CSNK2A1 |
| Interaction | PSKH1 interactions | 6.25e-07 | 65 | 51 | 5 | int:PSKH1 | |
| Interaction | ZNF48 interactions | 2.02e-06 | 149 | 51 | 6 | int:ZNF48 | |
| Interaction | SRSF5 interactions | 2.58e-06 | 474 | 51 | 9 | int:SRSF5 | |
| Interaction | SNRNP70 interactions | CDK8 SRSF10 RPL36AL RPL36A BCLAF1 SF3A1 DYRK1A SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 4.66e-06 | 984 | 51 | 12 | int:SNRNP70 |
| Interaction | TSSK6 interactions | 5.99e-06 | 47 | 51 | 4 | int:TSSK6 | |
| Interaction | RPL31 interactions | ZNF346 RPL36AL TENT4B RPL36A SUPT6H BCLAF1 PDCD11 URB2 RPL8 FTSJ3 | 6.55e-06 | 680 | 51 | 10 | int:RPL31 |
| Interaction | PRKRA interactions | 6.78e-06 | 400 | 51 | 8 | int:PRKRA | |
| Interaction | CBX6 interactions | 6.82e-06 | 283 | 51 | 7 | int:CBX6 | |
| Interaction | DHX8 interactions | 8.37e-06 | 292 | 51 | 7 | int:DHX8 | |
| Interaction | SRSF7 interactions | 1.05e-05 | 425 | 51 | 8 | int:SRSF7 | |
| Interaction | ZC3H10 interactions | 1.10e-05 | 200 | 51 | 6 | int:ZC3H10 | |
| Interaction | NIFK interactions | 1.17e-05 | 431 | 51 | 8 | int:NIFK | |
| Interaction | OBSL1 interactions | SRSF10 RPL36AL SUPT6H BCLAF1 SF3A1 DYRK1A PDCD11 URB2 THRAP3 RPL8 FTSJ3 | 1.25e-05 | 902 | 51 | 11 | int:OBSL1 |
| Interaction | MECP2 interactions | SRSF10 RPL36AL RPL36A KALRN SUPT6H BCLAF1 SF3A1 PDCD11 URB2 SNRPC THRAP3 MRPS22 RPL8 | 1.34e-05 | 1287 | 51 | 13 | int:MECP2 |
| Interaction | LARP7 interactions | ZNF346 RPL36AL RPL36A SF3A1 PEX1 PDCD11 SNRPC THRAP3 MRPS22 FKBP5 RPL8 FTSJ3 | 1.62e-05 | 1113 | 51 | 12 | int:LARP7 |
| Interaction | TRIM31 interactions | 1.70e-05 | 454 | 51 | 8 | int:TRIM31 | |
| Interaction | SRPK1 interactions | 2.42e-05 | 477 | 51 | 8 | int:SRPK1 | |
| Interaction | DDX23 interactions | 2.53e-05 | 480 | 51 | 8 | int:DDX23 | |
| Interaction | MYCN interactions | ZNF346 SRSF10 RPL36AL RPL36A MICAL2 BCLAF1 SF3A1 PDCD11 SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 2.67e-05 | 1373 | 51 | 13 | int:MYCN |
| Interaction | SNRNP40 interactions | 2.76e-05 | 637 | 51 | 9 | int:SNRNP40 | |
| Interaction | DOT1L interactions | SRSF10 RPL36AL TENT4B RPL36A SF3A1 PDCD11 THRAP3 MRPS22 RPL8 FTSJ3 | 2.88e-05 | 807 | 51 | 10 | int:DOT1L |
| Interaction | ANOS1 interactions | 3.03e-05 | 143 | 51 | 5 | int:ANOS1 | |
| Interaction | CDKL2 interactions | 3.12e-05 | 71 | 51 | 4 | int:CDKL2 | |
| Interaction | LUC7L interactions | 3.23e-05 | 242 | 51 | 6 | int:LUC7L | |
| Interaction | APOBEC3D interactions | 3.57e-05 | 148 | 51 | 5 | int:APOBEC3D | |
| Interaction | DHX40 interactions | 3.79e-05 | 249 | 51 | 6 | int:DHX40 | |
| Interaction | RC3H2 interactions | SRSF10 RPL36AL RPL36A BCLAF1 PDCD11 SNRPC THRAP3 MRPS22 RPL8 | 3.96e-05 | 667 | 51 | 9 | int:RC3H2 |
| Interaction | MEN1 interactions | SRSF10 RPL36AL TENT4B RPL36A BCLAF1 SF3A1 PDCD11 THRAP3 MRPS22 RPL8 FTSJ3 | 4.23e-05 | 1029 | 51 | 11 | int:MEN1 |
| Interaction | AATF interactions | 4.25e-05 | 376 | 51 | 7 | int:AATF | |
| Interaction | ZNF512 interactions | 4.42e-05 | 256 | 51 | 6 | int:ZNF512 | |
| Interaction | HNRNPU interactions | RPL36A BCLAF1 SF3A1 GNPTAB PDCD11 SNRPC THRAP3 MRPS22 FKBP5 RPL8 FTSJ3 | 4.46e-05 | 1035 | 51 | 11 | int:HNRNPU |
| Interaction | FGFBP1 interactions | 4.52e-05 | 257 | 51 | 6 | int:FGFBP1 | |
| Interaction | RRP8 interactions | 4.72e-05 | 259 | 51 | 6 | int:RRP8 | |
| Interaction | MAK16 interactions | 5.50e-05 | 162 | 51 | 5 | int:MAK16 | |
| Interaction | TBCK interactions | 5.50e-05 | 82 | 51 | 4 | int:TBCK | |
| Interaction | CAND1 interactions | ZNF346 SRSF10 BCLAF1 SF3A1 PDCD11 SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 6.85e-05 | 894 | 51 | 10 | int:CAND1 |
| Interaction | SRPK2 interactions | 6.92e-05 | 717 | 51 | 9 | int:SRPK2 | |
| Interaction | RPL14 interactions | 6.97e-05 | 554 | 51 | 8 | int:RPL14 | |
| Interaction | HEXIM1 interactions | RPL36AL RPL36A SF3A1 ZNF735 DYRK1A SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 8.16e-05 | 913 | 51 | 10 | int:HEXIM1 |
| Interaction | SRSF1 interactions | 8.50e-05 | 570 | 51 | 8 | int:SRSF1 | |
| Interaction | RNPS1 interactions | 9.18e-05 | 425 | 51 | 7 | int:RNPS1 | |
| Interaction | RPL13A interactions | 1.09e-04 | 591 | 51 | 8 | int:RPL13A | |
| Interaction | SRPK3 interactions | 1.17e-04 | 190 | 51 | 5 | int:SRPK3 | |
| Interaction | UTP23 interactions | 1.20e-04 | 191 | 51 | 5 | int:UTP23 | |
| Interaction | POLR2E interactions | 1.23e-04 | 308 | 51 | 6 | int:POLR2E | |
| Interaction | PRKACG interactions | 1.24e-04 | 101 | 51 | 4 | int:PRKACG | |
| Interaction | RPL18A interactions | 1.26e-04 | 447 | 51 | 7 | int:RPL18A | |
| Interaction | RPL5 interactions | 1.30e-04 | 606 | 51 | 8 | int:RPL5 | |
| Interaction | RPA4 interactions | 1.35e-04 | 452 | 51 | 7 | int:RPA4 | |
| Interaction | PRC1 interactions | SRSF10 RPL36AL BCLAF1 SF3A1 PDCD11 URB2 SNRPC THRAP3 RPL8 FTSJ3 | 1.38e-04 | 973 | 51 | 10 | int:PRC1 |
| Interaction | MTBP interactions | 1.41e-04 | 40 | 51 | 3 | int:MTBP | |
| Interaction | RBM4 interactions | 1.48e-04 | 319 | 51 | 6 | int:RBM4 | |
| Interaction | CCDC137 interactions | 1.48e-04 | 200 | 51 | 5 | int:CCDC137 | |
| Interaction | NR2C2 interactions | SRSF10 RPL36AL RPL36A SF3A1 JAZF1 PDCD11 SNRPC THRAP3 MRPS22 FKBP5 RPL8 FTSJ3 | 1.54e-04 | 1403 | 51 | 12 | int:NR2C2 |
| Interaction | H2AB2 interactions | 1.55e-04 | 107 | 51 | 4 | int:H2AB2 | |
| Interaction | MED17 interactions | 1.56e-04 | 202 | 51 | 5 | int:MED17 | |
| Interaction | BARD1 interactions | 1.59e-04 | 323 | 51 | 6 | int:BARD1 | |
| Interaction | NPM1 interactions | RPL36AL TENT4B BCLAF1 SCML1 DYRK1A PDCD11 AIP NEB MRPS22 RPL8 FTSJ3 | 1.69e-04 | 1201 | 51 | 11 | int:NPM1 |
| Interaction | PRP4K interactions | 1.75e-04 | 329 | 51 | 6 | int:PRP4K | |
| Interaction | RBM8A interactions | 1.78e-04 | 473 | 51 | 7 | int:RBM8A | |
| Interaction | TRA2A interactions | 1.78e-04 | 330 | 51 | 6 | int:TRA2A | |
| Interaction | CCDC59 interactions | 1.85e-04 | 112 | 51 | 4 | int:CCDC59 | |
| Interaction | FBXW7 interactions | CDK8 ZNF346 SRSF10 IGFBP3 SUPT6H BCLAF1 DYRK1A VPS16 THRAP3 FKBP5 RPL8 | 1.87e-04 | 1215 | 51 | 11 | int:FBXW7 |
| Interaction | SUZ12 interactions | 1.97e-04 | 644 | 51 | 8 | int:SUZ12 | |
| Interaction | RSBN1L interactions | 1.98e-04 | 114 | 51 | 4 | int:RSBN1L | |
| Interaction | SNRPA interactions | 2.00e-04 | 482 | 51 | 7 | int:SNRPA | |
| Interaction | RBBP6 interactions | 2.12e-04 | 216 | 51 | 5 | int:RBBP6 | |
| Interaction | ADARB1 interactions | 2.18e-04 | 489 | 51 | 7 | int:ADARB1 | |
| Interaction | KIF23 interactions | SRSF10 MICAL2 BCLAF1 DYRK1A PDCD11 SNRPC THRAP3 MRPS22 RPL8 FTSJ3 | 2.21e-04 | 1031 | 51 | 10 | int:KIF23 |
| Interaction | WWP2 interactions | 2.29e-04 | 840 | 51 | 9 | int:WWP2 | |
| Interaction | RPL28 interactions | 2.32e-04 | 494 | 51 | 7 | int:RPL28 | |
| Interaction | RPLP0 interactions | 2.33e-04 | 660 | 51 | 8 | int:RPLP0 | |
| Interaction | PURG interactions | 2.46e-04 | 223 | 51 | 5 | int:PURG | |
| Interaction | SRSF6 interactions | 2.59e-04 | 503 | 51 | 7 | int:SRSF6 | |
| Interaction | H3C6 interactions | 2.62e-04 | 226 | 51 | 5 | int:H3C6 | |
| Interaction | ZC3H3 interactions | 2.62e-04 | 226 | 51 | 5 | int:ZC3H3 | |
| Interaction | CDK12 interactions | 2.73e-04 | 228 | 51 | 5 | int:CDK12 | |
| Interaction | RC3H1 interactions | 2.76e-04 | 677 | 51 | 8 | int:RC3H1 | |
| Interaction | PYHIN1 interactions | 2.77e-04 | 358 | 51 | 6 | int:PYHIN1 | |
| Interaction | RNF2 interactions | 2.87e-04 | 866 | 51 | 9 | int:RNF2 | |
| Interaction | SF3B2 interactions | 3.06e-04 | 517 | 51 | 7 | int:SF3B2 | |
| Interaction | RPS6 interactions | 3.07e-04 | 874 | 51 | 9 | int:RPS6 | |
| Interaction | RPF2 interactions | 3.20e-04 | 236 | 51 | 5 | int:RPF2 | |
| Interaction | RPL13 interactions | 3.46e-04 | 700 | 51 | 8 | int:RPL13 | |
| Interaction | RPS24 interactions | 3.51e-04 | 529 | 51 | 7 | int:RPS24 | |
| Interaction | RPL15 interactions | 3.55e-04 | 530 | 51 | 7 | int:RPL15 | |
| Interaction | SETD2 interactions | 3.77e-04 | 135 | 51 | 4 | int:SETD2 | |
| Interaction | MAU2 interactions | 3.88e-04 | 136 | 51 | 4 | int:MAU2 | |
| Interaction | DNAJC12 interactions | 4.06e-04 | 57 | 51 | 3 | int:DNAJC12 | |
| Interaction | DDX21 interactions | 4.10e-04 | 718 | 51 | 8 | int:DDX21 | |
| Interaction | LLPH interactions | 4.21e-04 | 139 | 51 | 4 | int:LLPH | |
| Interaction | RPL3 interactions | 4.25e-04 | 722 | 51 | 8 | int:RPL3 | |
| Interaction | CFH interactions | 4.33e-04 | 140 | 51 | 4 | int:CFH | |
| Interaction | MYO10 interactions | 4.45e-04 | 141 | 51 | 4 | int:MYO10 | |
| Interaction | PUM3 interactions | 4.48e-04 | 254 | 51 | 5 | int:PUM3 | |
| Cytoband | 6p21.31 | 9.65e-04 | 41 | 51 | 2 | 6p21.31 | |
| Cytoband | 22q12.2 | 1.92e-03 | 58 | 51 | 2 | 22q12.2 | |
| Cytoband | 19q13.4 | 3.53e-03 | 79 | 51 | 2 | 19q13.4 | |
| GeneFamily | L ribosomal proteins | 1.09e-04 | 51 | 33 | 3 | 729 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.34e-04 | 15 | 33 | 2 | 696 | |
| GeneFamily | FKBP prolyl isomerases | 4.85e-04 | 18 | 33 | 2 | 910 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 6.01e-04 | 20 | 33 | 2 | 1371 | |
| GeneFamily | Cyclin dependent kinases | 1.02e-03 | 26 | 33 | 2 | 496 | |
| GeneFamily | Cyclins|Mediator complex | 1.65e-03 | 33 | 33 | 2 | 1061 | |
| GeneFamily | WD repeat domain containing | 1.19e-02 | 262 | 33 | 3 | 362 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-06 | 185 | 51 | 5 | f60b39010b9210a5f18ccd113758512bd15d7eec | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 194 | 51 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (14)_Tcm|World / shred on Cell_type and subtype | 3.88e-06 | 207 | 51 | 5 | 5521742c28b99d5e3119da11bd56a33bd4243bb3 | |
| ToppCell | (16)_Tfh|World / shred on Cell_type and subtype | 3.98e-06 | 208 | 51 | 5 | aacd9b13d08debe212b5183c94378f9cc655ff55 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-05 | 165 | 51 | 4 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 170 | 51 | 4 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | Severe-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.35e-05 | 180 | 51 | 4 | bc20e581d37cba72b71ef62df60475a0ccee9994 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-05 | 186 | 51 | 4 | 3dae539cce15fcf2b1b32e981d7febe94c03c600 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 188 | 51 | 4 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | droplet-Lung-30m-Hematologic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-05 | 188 | 51 | 4 | 614b6b83b54bceaf213698310cbb97139bf8dce2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.73e-05 | 191 | 51 | 4 | f398344aaa79fc93d792e241b634a6afe4aff33d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 191 | 51 | 4 | 11da47d96f44ba629e3299667495e7daddbbe86c | |
| ToppCell | tumor_Lung-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 6.73e-05 | 191 | 51 | 4 | 4eecf2d7f434f3787a9bd7b572d6fde10c751c14 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.73e-05 | 191 | 51 | 4 | ffcb2c8dbcf40281b439f4b719b5b341972ffb9a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.73e-05 | 191 | 51 | 4 | ffe88d1ad676c745c76db89f766062fd365329f4 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 6.87e-05 | 192 | 51 | 4 | ad7207810116e73d461242e42071901b6a9f48c6 | |
| ToppCell | remission-CD4+_T_naive|remission / disease stage, cell group and cell class | 6.87e-05 | 192 | 51 | 4 | d96b2122e28c735d8002ad6eb2d3d52c8e9ccf2b | |
| ToppCell | COVID-19_Convalescent-CD4+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 7.01e-05 | 193 | 51 | 4 | 346caaf288217acaf232060629ce964a07f63432 | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 7.01e-05 | 193 | 51 | 4 | 8f8c4a45fe3eb13717501f6dad59bcb43a959b85 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 7.15e-05 | 194 | 51 | 4 | 8a6b2405944b0bea52c5e81083a977e52731b347 | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.29e-05 | 195 | 51 | 4 | 211eba45a502b961873ca2d4642f7852e6e89d7a | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.29e-05 | 195 | 51 | 4 | 8cd7667a65d77dd7b301090a9b65aba254741375 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.29e-05 | 195 | 51 | 4 | def0a3fb36eec6fbb08e1323baf2b22b28bf751a | |
| ToppCell | (0)_Normal/No_Treatment-(0)_LMPP_(LSK_cells)|World / Stress and Cell class | 7.44e-05 | 196 | 51 | 4 | 16a23ef14c6e054634873298a320c23ea0444780 | |
| ToppCell | normal_Pleural_Fluid|World / Location, Cell class and cell subclass | 7.44e-05 | 196 | 51 | 4 | 7029c9f4a826f6cfdcb5f7a472fba94e8945a771 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 7.44e-05 | 196 | 51 | 4 | 9cc517373ce4374140ab153edc87ec5517ee1f63 | |
| ToppCell | Control-CD4+_T_naive|Control / Disease condition and Cell class | 7.44e-05 | 196 | 51 | 4 | 10455dd24d4a4466eeecb22949b83085e8333ad2 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_Naive|IIF / Disease, Lineage and Cell Type | 7.58e-05 | 197 | 51 | 4 | 8fb7afe64caf46dd6cf0a5ed859b86b79e3595c5 | |
| ToppCell | lymphoid-T_cell-CD4+_Naive_T_cell|lymphoid / Lineage, cell class and subclass | 7.58e-05 | 197 | 51 | 4 | d965cf45e6a6528bb405ee04f20876a8403c8df8 | |
| ToppCell | COVID-19_Mild-CD4+_T_naive|COVID-19_Mild / Disease condition and Cell class | 7.58e-05 | 197 | 51 | 4 | 3aea21819cbedb3bcdb74ae2e7f963a44b53ed52 | |
| ToppCell | (0)_Normal/No_Treatment-(0)_LMPP_(LSK_cells)|(0)_Normal/No_Treatment / Stress and Cell class | 7.58e-05 | 197 | 51 | 4 | 23d069be60e6aa49858906283e384bb3284791b6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.58e-05 | 197 | 51 | 4 | 076fc05b32200e0a8a1e35d03c295111468d92a9 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.73e-05 | 198 | 51 | 4 | 5024d43b4cf7dea305ed911f1e123ca7fd44e990 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 7.73e-05 | 198 | 51 | 4 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-Treg|IIF / Disease, condition lineage and cell class | 7.73e-05 | 198 | 51 | 4 | 7bbf8403ecf9f8e403b04f18d265ece977cc49e7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 199 | 51 | 4 | 1b74f6fbf2628f335ba5eb49b679d2f72068bbbe | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.89e-05 | 199 | 51 | 4 | 714f7266733becf885226fe83cf29daa91412360 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.89e-05 | 199 | 51 | 4 | 55a53949fac7534aa83cfc845131e02032eec5f7 | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.89e-05 | 199 | 51 | 4 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.89e-05 | 199 | 51 | 4 | 551f4f4364a711efe133d38e29cd43c78bffaaa1 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD4+_Tem|IIF / Disease, condition lineage and cell class | 7.89e-05 | 199 | 51 | 4 | a876d53a9cc5d1584bed5ff679be8f5273daad37 | |
| ToppCell | Parenchymal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 7.89e-05 | 199 | 51 | 4 | cce684df78421b814083aed16c4cbbac5f287bbc | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 199 | 51 | 4 | a660f7373fca03929234cbd936735f97883fb689 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.89e-05 | 199 | 51 | 4 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.89e-05 | 199 | 51 | 4 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_Tem|Multiple_Sclerosis / Disease, condition lineage and cell class | 7.89e-05 | 199 | 51 | 4 | 79145d931a250c69a643936fea147e2bd50b4d6d | |
| ToppCell | VE-CD4|VE / Condition, Cell_class and T cell subcluster | 8.04e-05 | 200 | 51 | 4 | f3b778b1f20c2b1e6d623df776e470a57cb1a842 | |
| ToppCell | mLN|World / shred on region, Cell_type, and subtype | 8.04e-05 | 200 | 51 | 4 | 9c1617dfde9d9aaa260bbad45b7d0b9caa41e15f | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD4+_T_naive|IIF / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | fccc4244a87b3e85e8d53285987710aeeb500415 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.04e-05 | 200 | 51 | 4 | b340b6acf675c75adffb98e560080f966571f594 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 729873094526b7752b91470f4a7281af7d57dbf9 | |
| ToppCell | mLN|World / Region, Cell class and subclass | 8.04e-05 | 200 | 51 | 4 | d8f76374a61db45a689ad2c338d35609629a3199 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD8+_Tcm|IIF / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 01554c0b7b8d7a12d99853fe057a20ed775ee5b2 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK|IIF / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 403e956d5a770811298694081b55e47e4ca2d814 | |
| ToppCell | IIF-Lymphocyte-T_NK|IIF / Disease, Lineage and Cell Type | 8.04e-05 | 200 | 51 | 4 | 50f2ae32e8792e2292e0113b7b27450b8dc33080 | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; HL60; HT_HG-U133A | 5.21e-06 | 198 | 51 | 6 | 2986_UP | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; HL60; HT_HG-U133A | 5.21e-06 | 198 | 51 | 6 | 3022_UP | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 2.38e-06 | 2 | 46 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | Abnormal behavior | 2.81e-04 | 16 | 46 | 2 | C0233514 | |
| Disease | serum gamma-glutamyl transferase measurement | 4.99e-04 | 914 | 46 | 7 | EFO_0004532 | |
| Disease | alpha fetoprotein measurement | 5.16e-04 | 100 | 46 | 3 | EFO_0010583 | |
| Disease | Down syndrome (is_marker_for) | 5.38e-04 | 22 | 46 | 2 | DOID:14250 (is_marker_for) | |
| Disease | osteoarthritis, hip, body mass index | 1.01e-03 | 30 | 46 | 2 | EFO_0004340, EFO_1000786 | |
| Disease | stroke | 1.48e-03 | 144 | 46 | 3 | EFO_0000712 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NDYLKYHKAKHEGEK | 1506 | Q14146 | |
| TYGHVYKARRKDGKD | 31 | Q9BWU1 | |
| DSSHKKERKVYNDGY | 126 | Q13627 | |
| YDDNVKAYFKRGKAH | 261 | O00170 | |
| NQYYHGKKRKHKRDA | 551 | Q8NDF8 | |
| DKVYVHYKGKLSNGK | 51 | Q13451 | |
| RKAGLALSKHYKVYK | 236 | Q8TAT5 | |
| IHKAYKDKNKYRFEI | 1101 | Q3T906 | |
| KKRYKNVNGIKYHAK | 181 | Q86VZ6 | |
| IKDSSGHTKYVYKNK | 1511 | O60229 | |
| GYSYKRGKDLKEQHD | 191 | Q96FE7 | |
| HKVTQYKKGKDSLYA | 21 | Q969Q0 | |
| KAGRAYHKYKAKRNC | 181 | P62917 | |
| EYQKARAKKKYIEHR | 931 | Q9GZU2 | |
| YGHIGRKYQSKKKLN | 516 | Q8NFZ0 | |
| KQHDTLVEYHKKYGK | 81 | Q07973 | |
| GKYKKKSHYYRDQRR | 481 | Q96S94 | |
| KEYKSYKDDSKHKRE | 731 | Q9NYF8 | |
| KLIGYFKSKDSEHYK | 181 | P31415 | |
| KRYKFVATGHGKYEK | 316 | P33241 | |
| HSKGKRDRKKRVYDY | 6966 | Q8NDH2 | |
| YYNKRILHKTKGKRF | 101 | Q6ZN32 | |
| TYGHVYKAKRKDGKD | 31 | P49336 | |
| KADAEYKKLHSYGRD | 191 | O43933 | |
| WYKLDKRGSHKEYKR | 66 | O94851 | |
| KKGHAKDSQRYKVDY | 176 | P17936 | |
| HHKTYEDIDKRGKYD | 246 | P82650 | |
| KQERAKYHKLKYGTE | 126 | Q13033 | |
| HKRYGYKKHSYRLVK | 101 | Q9UN30 | |
| EYALKQERAKYHKLK | 106 | O43815 | |
| SGRKHKENVKDYYQK | 26 | P09234 | |
| KKYLDQEKEDGKYHK | 76 | Q8WV92 | |
| HKVTQYKKGKDSLYA | 21 | P83881 | |
| EGKKYIVAYHAAGKK | 226 | Q96PZ0 | |
| YKKAGLGKEKRHVTY | 786 | Q8IY81 | |
| HAYYRHKVSEFKEGK | 91 | Q15459 | |
| TKKGRKDVDEAHYAY | 621 | Q7KZ85 | |
| KRYLDYEKQHGTEKD | 1836 | Q14690 | |
| KYKNTEKFHRRIYKG | 86 | Q92738 | |
| KSKKYYLHDDREGEG | 876 | Q9Y2W1 | |
| NARYTGKKHLKCKKY | 176 | P0CB33 | |
| HTGEKAYKRREYGKS | 241 | Q6P9A3 | |
| HYKSGSRYEKESRKK | 216 | O75494 | |
| QHNKYEAKKYASRVG | 766 | Q9H269 | |
| CKDKNLAKYSAIYHK | 46 | Q6P2H8 | |
| DFEDSYKKYLHTVKK | 231 | Q86V25 | |
| YRAYATEPHAKKKSK | 26 | P19429 | |
| HYQSKKHANKVKRYL | 91 | Q9UL40 | |
| KQQSKLKHSTYKYGR | 26 | Q8NA23 | |
| KHYAGKVKYGVKDFR | 651 | B2RTY4 | |
| KYKEAYEKSKGKHVG | 1331 | P20929 | |
| REYKKGYEKSKTSFH | 1856 | P20929 | |
| KAKKATEYASDQKYR | 2191 | P20929 | |
| RLYKEDYHKTKAKIN | 4286 | P20929 | |
| SELKYKETYEKQKGH | 4491 | P20929 | |
| KETYEKQKGHYLAGK | 4496 | P20929 | |
| YKETFQKTKGKYHTV | 5266 | P20929 | |
| KYKDHVKKHLAQGSY | 5651 | P20929 |